Compare American Well Corp (AMWL) vs AstraZeneca plc (AZN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Well Corp vs AstraZeneca plc — how do they compare? American Well Corp trades at $11.08 (market cap $165.58M), while AstraZeneca plc trades at $170.44 (market cap $262.75B). The key difference: AstraZeneca plc is far larger — about 1586.8× American Well Corp's market cap, and AstraZeneca plc pays a 1.84% dividend while American Well Corp pays none. Which is the better fit depends on your goals.
| AMWL | AZN | |
|---|---|---|
Market Cap | $165.58M | $262.75B |
Sector | Health | Health |
52-Week High | $9.91 | $209.48 |
52-Week Low | $3.78 | $137.44 |
Enterprise Value | -$9.66M | $289.00B |
Dividend Yield | — | 1.84% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →
